Pushing the limits of sulfur SAD phasing: de novo structure solution of the N-terminal domain of the ectodomain of HCV E1. by El Omari, K, Iourin, O, Kadlec, J, Fearn, R, Hall, DR, Harlos, K, Grimes, J, Stuart, D

Molecular recycling within amyloid fibrils. by Carulla, N, Caddy, G, Hall, DR, Zurdo, J, Gairí, M, Feliz, M, Giralt, E, Robinson, C, Dobson, C

Where is crystallography going? by Grimes, JM, Hall, DR, Ashton, AW, Evans, G, Owen, RL, Wagner, A, Mcauley, KE, von Delft, F, Orville, AM, Sorensen, T, Walsh, MA, Ginn, HM, Stuart, DI

High-throughput sample handling and data collection at synchrotrons: embedding the ESRF into the high-throughput gene-to-structure pipeline. by Beteva, A, Cipriani, F, Cusack, S, Delageniere, S, Gabadinho, J, Gordon, E, Guijarro, M, Hall, DR, Larsen, S, Launer, L, Lavault, C, Leonard, G, Mairs, T, McCarthy, A, McCarthy, J, Meyer, J, Mitchell, E, Monaco, S, Nurizzo, D, Pernot, P, Pieritz, R, Ravelli, R, Rey, V, Shepard, W, Spruce, D

Application of in situ diffraction in high-throughput structure determination platforms. by Aller, P, Sanchez-Weatherby, J, Foadi, J, Winter, G, Lobley, C, Axford, D, Ashton, A, Bellini, D, Brandao-Neto, J, Culurgioni, S, Douangamath, A, Duman, R, Evans, G, Fisher, S, Flaig, R, Hall, DR, Lukacik, P, Mazzorana, M, McAuley, K, Mykhaylyk, V, Owen, R, Paterson, N, Romano, P, Sandy, J, Sorensen, T

The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants by Liu, C, Zhou, D, Nutalai, R, Duyvesteyn, HME, Tuekprakhon, A, Ginn, HM, Dejnirattisai, W, Supasa, P, Mentzer, AJ, Wang, B, Case, JB, Zhao, Y, Skelly, DT, Chen, RE, Johnson, SA, Ritter, TG, Mason, C, Malik, T, Temperton, N, Paterson, NG, Williams, MA, Hall, DR, Clare, DK, Howe, A, Goulder, PJR, Fry, EE, Diamond, MS, Mongkolsapaya, J, Ren, J, Stuart, DI, Screaton, GR

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees by Nutalai, R, Zhou, D, Tuekprakhon, A, Ginn, HM, Supasa, P, Liu, C, Huo, J, Mentzer, AJ, Duyvesteyn, HME, Dijokaite-Guraliuc, A, Skelly, D, Ritter, TG, Amini, A, Bibi, S, Adele, S, Johnson, SA, Constantinides, B, Webster, H, Temperton, N, Klenerman, P, Barnes, E, Dunachie, SJ, Crook, D, Pollard, AJ, Lambe, T, Goulder, P, Paterson, NG, Williams, MA, Hall, DR, Mongkolsapaya, J, Fry, EE, Dejnirattisai, W, Ren, J, Stuart, DI, Screaton, GR

Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum by Tuekprakhon, A, Nutalai, R, Dijokaite-Guraliuc, A, Zhou, D, Ginn, HM, Selvaraj, M, Liu, C, Mentzer, AJ, Supasa, P, Duyvesteyn, HME, Das, R, Skelly, D, Ritter, TG, Amini, A, Bibi, S, Adele, S, Johnson, SA, Constantinides, B, Webster, H, Temperton, N, Klenerman, P, Barnes, E, Dunachie, SJ, Crook, D, Pollard, AJ, Lambe, T, Goulder, P, Paterson, NG, Williams, MA, Hall, DR, ISARIC4C Consortium, Fry, EE, Huo, J, Mongkolsapaya, J, Ren, J, Stuart, DI, Screaton, GR

A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75 by Huo, J, Dijokaite-Guraliuc, A, Liu, C, Zhou, D, Ginn, HM, Das, R, Supasa, P, Selvaraj, M, Nutalai, R, Tuekprakhon, A, Duyvesteyn, HME, Mentzer, AJ, Skelly, D, Ritter, TG, Amini, A, Bibi, S, Adele, S, Johnson, SA, Paterson, NG, Williams, MA, Hall, DR, Plowright, M, Newman, TAH, Hornsby, H, de Silva, TI, Temperton, N, Klenerman, P, Barnes, E, Dunachie, SJ, Pollard, AJ, Lambe, T, Goulder, P, OPTIC consortium, ISARIC4C consortium, Fry, EE, Mongkolsapaya, J, Ren, J, Stuart, DI, Screaton, GR

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera by Supasa, P, Zhou, D, Dejnirattisai, W, Liu, C, Mentzer, AJ, Ginn, HM, Zhao, Y, Duyvesteyn, HME, Nutalai, R, Tuekprakhon, A, Wang, B, Paesen, GC, Slon-Campos, J, López-Camacho, C, Hallis, B, Coombes, N, Bewley, KR, Charlton, S, Walter, TS, Barnes, E, Dunachie, SJ, Skelly, D, Lumley, SF, Baker, N, Shaik, I, Humphries, HE, Godwin, K, Gent, N, Sienkiewicz, A, Dold, C, Levin, R, Pollard, AJ, Dong, T, Screaton, GR, Knight, JC, Klenerman, P, Crook, D, Lambe, T, Clutterbuck, E, Bibi, S, Flaxman, A, Bittaye, M, Belij-Rammerstorfer, S, Gilbert, S, Hall, DR, Williams, MA, Paterson, NG, James, W, Carroll, MW, Fry, EE, Mongkolsapaya, J, Stuart, DI

Antibody evasion by the P.1 strain of SARS-CoV-2 by Dejnirattisai, W, Zhou, D, Supasa, P, Liu, C, Mentzer, AJ, Ginn, HM, Zhao, Y, Duyvesteyn, HME, Tuekprakhon, A, Nutalai, R, Wang, B, López-Camacho, C, Slon-Campos, J, Walter, TS, Skelly, D, Costa Clemens, SA, Naveca, FG, Nascimento, V, Nascimento, F, Fernandes da Costa, C, Resende, PC, Pauvolid-Correa, A, Siqueira, MM, Dold, C, Levin, R, Dong, T, Pollard, AJ, Knight, JC, Crook, D, Lambe, T, Clutterbuck, E, Bibi, S, Flaxman, A, Bittaye, M, Belij-Rammerstorfer, S, Gilbert, SC, Carroll, MW, Klenerman, P, Barnes, E, Dunachie, SJ, Paterson, NG, Williams, MA, Hall, DR, Hulswit, RJG, Bowden, TA, Fry, EE, Mongkolsapaya, J, Ren, J, Stuart, DI, Screaton, GR

The antigenic anatomy of SARS-CoV-2 receptor binding domain by Dejnirattisai, W, Zhou, D, Ginn, HM, Duyvesteyn, HME, Spasa, D, Case, JB, Zhao, Y, Walter, TS, Mentzer, AJ, Liu, C, Wang, B, Paesen, GC, Slon-Campus, J, López-Camacho, C, Kafai, NM, Bailey, AL, Chen, RE, Ying, B, Thompson, C, Bolton, J, Fyfe, A, Gupta, S, Tan, TK, Gilbert-Jaramillo, J, James, W, Knight, M, Carroll, MW, Skelly, D, Dold, C, Peng, Y, Levin, R, Dong, T, Pollard, AJ, Knight, JC, Klenerman, P, Temperton, N, Hall, DR, Williams, MA, Paterson, NG, Bertram, FKR, Seibert, CA, Clare, DK, Howe, A, Raedecke, J, Song, Y, Townsend, AR, Huang, K-YA, Fry, EE, Mongkolsapaya, J, Diamond, MS, Ren, J, Stuart, DI, Screaton, GR